(MedPage Today) — Some 25 million children and teens — often those with chronic illnesses — had inadequate health insurance or none at all in 2007, a federal study found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has issued a class I recall — the agency’s most serious — for the nitric oxide delivery system Inomax because of a pressure switch problem that could be fatal.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Francis Collins, MD, director of the National Institutes of Health (NIH), said Tuesday that he was “stunned” by the preliminary injunction granted by a federal judge who ruled NIH funding of stem cell research violates federal law.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has issued a class I recall — the agency’s most serious — for the nitric oxide delivery system Inomax because of a pressure switch problem that could be fatal.
No Comments »
Filed under: Pharmacy News
CHX Technologies Inc., a private Canadian pharmaceutical company that is developing new treatments for the prevention of dental diseases, today announced successful results in its final controlled pivotal trial of Prevora, its proprietary antibacterial tooth coating for the prevention of cavities. The trial surpassed objectives set by the Food and Drug Administration (FDA) protocol, clearing [...]
No Comments »
Filed under: Pharmacy News
ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc., today announced that the National Institute of Health/National Institute of Allergy and Infectious Disease, has awarded its research partner, the University of Rochester Medical Center (URMC), a $15 million five-year, continuation grant for studies that will utilize ImmuneRegen’s Homspera.
No Comments »
Filed under: Pharmacy News
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. [...]
No Comments »
Filed under: Pharmacy News
ZymoGenetics, Inc. today announced enrollment has been completed in the Phase 2b clinical trial with PEG-Interferon lambda and ribavirin in chronic hepatitis C virus (HCV) infection.
No Comments »
Filed under: Pharmacy News
Tranzyme Pharma announced today that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present ulimorelin Phase 2 data at this year’s Joint International NGM Meeting on Saturday, August 28, 2010.
No Comments »
Filed under: Pharmacy News
The double-blind, placebo-controlled, parallel-group study (Study 306) showed that perampanel was well-tolerated and effective in reducing median seizure frequency and increasing responder rates, the primary outcome measures in the United States and European Union, respectively. The findings were highly statistically significant in 4 mg and 8 mg doses compared to placebo.
No Comments »
Filed under: Pharmacy News
